Skip to content

Effects of Diet Manipulation on Women in the Curves Program

Effects of a Carbohydrate Restricted, High Protein, High Fat Diet on Weight Loss and Health Outcomes in Women Participating in the Curves Fitness and Weight Loss Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03093792
Acronym
Curves2
Enrollment
86
Registered
2017-03-28
Start date
2013-09-01
Completion date
2015-05-01
Last updated
2017-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet, Carbohydrate-Restricted

Brief summary

The purpose of this study is to look at the effects of a carbohydrate restricted, high protein, high fat diet on weight loss and health outcomes in women participating in the Curves Fitness and Weight Loss Program.

Detailed description

The purpose of this study is to determine if a carbohydrate restricted, high protein, high fat diet (20% carbohydrate, 45% protein, 35% fat; CC-II) promotes more favorable changes in weight loss and health outcomes compared to a traditional high carbohydrate, low protein, low fat diet (55% carbohydrate, 15% protein, 30% fat; AHA) and the Curves moderate carbohydrate restricted, high protein, and low fat diet (30% carbohydrate, 45% protein, 25% fat; CC-I).

Interventions

OTHERControl
OTHERAmerican Heart Association plus exercise
OTHERCurves Complete - I plus exercise
OTHERCurves Complete - II plus exercise

Sponsors

Curves International
CollaboratorINDUSTRY
Texas A&M University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* The participant is an apparently healthy female * The participant is between the ages of 18 and 60

Exclusion criteria

* The participant is pregnant or nursing, or plans to become pregnant during the next 12 months or has been pregnant in the past 12 months * The participant has uncontrolled metabolic disorder including known electrolyte abnormalities; heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; a history of hypertension, hepatorenal, musculoskeletal, autoimmune, or neurological disease * The participant is currently taking thyroid, hyperlipidemic, hypoglycemic, anti-hypertensive, or androgenic medications * The participant has taken ergogenic levels of nutritional supplements that may affect muscle mass (e.g., creatine, HMB), anabolic/catabolic hormone levels (androstenedione, DHEA, etc.) or weight loss (e.g., ephedra, thermogenics, etc.) within the past three months * The participant is willing to participate in a regular moderate exercise program

Design outcomes

Primary

MeasureTime frame
Effects of the Curves program on lipid panels24 weeks
Effects of the Curves program on Bioelectrical Impedance Analysis (BIA)24 weeks
Effects of the Curves program on a chemistry-15 blood panel24 weeks
Effects of the Curves program on a cell blood count (CBC) blood panel24 weeks
Effects of the Curves program on physical activity patterns24 weeks
Effects of the Curves program on body weight24 weeks
Effects of the Curves program on the hip/waist ratio24 weeks
Effects of the Curves program on Resting Energy Expenditure (REE)24 weeks
Effects of the Curves program on Blood Pressure (BP)24 weeks
Effects of the Curves program on Heart Rate (HR)24 weeks
Effects of the Curves program on body composition (DXA)24 weeks

Secondary

MeasureTime frame
Effects of the Curves program on maximal cardiopulmonary capacity24 weeks
Effects of the Curves program on muscular strength through a 1 repetition maximum (1 RM) test24 weeks
Effects of the Curves program on muscular endurance through a maximal repetition test24 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026